Addressing access inequality in CAR-T therapies

Francesca Del Bufalo, MD, Bambino Gesù Children's Hospital, Rome, Italy, addresses the issue of access inequality in CAR-T therapies. She explores advancements in manufacturing processes aimed at expanding the availability of CAR-T therapy across more centers. Additionally, Dr Del Bufalo discusses the potential for future mixed models of manufacturing involving entities beyond pharmaceutical companies, to mitigate the high costs associated with these treatments. This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.